Details for Patent: 7,780,987
Summary for Patent: 7,780,987
| Title: | Controlled release dosage forms |
| Abstract: | The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55° C. and an aqueous dispersion of a neutral ester copolymer lacking functional groups. |
| Inventor(s): | Fang Zhou, Paul Maes |
| Assignee: | Bausch Health Ireland Ltd |
| Application Number: | US10/370,109 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,780,987 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Process; Dosage form; |
Drugs Protected by US Patent 7,780,987
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,780,987
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 536173 | ⤷ Start Trial | |||
| Australia | 2003211145 | ⤷ Start Trial | |||
| Australia | 2003211146 | ⤷ Start Trial | |||
| Canada | 2476201 | ⤷ Start Trial | |||
| Canada | 2476496 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
